ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $904 | -100.0% | 19,600 | -58.6% | 0.00% | -80.0% |
| Q4 2021 | $3,986,000 | -38.3% | 47,400 | -33.8% | 0.01% | -37.5% |
| Q3 2021 | $6,458,000 | -85.4% | 71,600 | -84.5% | 0.01% | -85.5% |
| Q2 2021 | $44,090,000 | +167.4% | 462,400 | +219.3% | 0.06% | +161.9% |
| Q1 2021 | $16,487,000 | +25.6% | 144,800 | +52.7% | 0.02% | +50.0% |
| Q4 2020 | $13,123,000 | +281.0% | 94,800 | +74.3% | 0.01% | +100.0% |
| Q1 2016 | $3,444,000 | +1018.2% | 54,400 | +1600.0% | 0.01% | +600.0% |
| Q3 2015 | $308,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |